U.S. Justice Department Sues Walmart Over Role in Opioid Crisis
WEDNESDAY, Dec. 23, 2020 -- Walmart is being sued by the U.S. Justice Department for its alleged role in the nation's opioid crisis.
A civil complaint filed Tuesday says Walmart unlawfully distributed controlled substances to its pharmacies at the height of the crisis, the Associated Press reported. The company violated federal law by selling prescriptions for controlled substances that its pharmacists "knew were invalid," according to Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department civil division.
"Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders," Jason Dunn, the U.S. attorney in Colorado, claimed. "As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart's pharmacies ordered opioids in a way that went essentially unmonitored and unregulated."
Nearly two months ago, Walmart filed a lawsuit against the Justice Department and Drug Enforcement Administration. The company claims it is being blamed for the federal government's regulatory and enforcement failures in the opioid crisis, the AP reported. In the lawsuit, Walmart wants a federal judge to rule that the federal government has no basis to seek civil damages.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
MONDAY, Jan. 25, 2021 -- For patients with atrial fibrillation (AF), low-to-moderate alcohol intake is not associated with an increased risk for stroke or other cardiovascular...
FRIDAY, Jan. 22, 2021 -- Opioid use seems to contribute to the increasing incidence of pancreatic cancer (PC) in the United States, according to a study published online Jan. 6 in...
FRIDAY, Jan. 22, 2021 -- Rates of overdose deaths involving methamphetamine increased for all racial/ethnic groups from 2011 to 2018, according to a research letter published...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.